Wellington Management Group LLP Trims Stock Holdings in Encompass Health Co. (NYSE:EHC)

Wellington Management Group LLP lessened its stake in shares of Encompass Health Co. (NYSE:EHC) by 22.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,030,442 shares of the company’s stock after selling 1,189,732 shares during the quarter. Wellington Management Group LLP owned 4.00% of Encompass Health worth $372,211,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in EHC. BNP Paribas Financial Markets increased its holdings in Encompass Health by 38.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 38,397 shares of the company’s stock valued at $3,711,000 after purchasing an additional 10,591 shares during the last quarter. Townsquare Capital LLC acquired a new stake in shares of Encompass Health in the third quarter valued at $405,000. Point72 Asia Singapore Pte. Ltd. raised its holdings in shares of Encompass Health by 62.0% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 1,095 shares of the company’s stock valued at $106,000 after buying an additional 419 shares during the period. Benjamin Edwards Inc. lifted its stake in Encompass Health by 37.2% during the 3rd quarter. Benjamin Edwards Inc. now owns 6,298 shares of the company’s stock worth $609,000 after acquiring an additional 1,707 shares in the last quarter. Finally, Cinctive Capital Management LP boosted its holdings in Encompass Health by 33.5% during the 3rd quarter. Cinctive Capital Management LP now owns 38,381 shares of the company’s stock valued at $3,709,000 after acquiring an additional 9,626 shares during the period. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on EHC shares. Royal Bank of Canada reissued an “outperform” rating and set a $110.00 price target on shares of Encompass Health in a research report on Tuesday, February 11th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. KeyCorp boosted their target price on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Monday, February 10th. StockNews.com upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. Finally, Barclays upped their target price on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, February 7th. Ten investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $107.67.

Encompass Health Stock Performance

Shares of EHC opened at $101.27 on Wednesday. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 52-week low of $78.53 and a 52-week high of $104.55. The stock has a 50 day moving average price of $98.92 and a 200 day moving average price of $97.58. The company has a market capitalization of $10.20 billion, a price-to-earnings ratio of 22.71, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC) last posted its earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Research analysts predict that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.67%. Encompass Health’s dividend payout ratio (DPR) is presently 15.25%.

Insider Buying and Selling

In other news, CAO Andrew L. Price sold 5,042 shares of the firm’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 2.10% of the stock is currently owned by company insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.